These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14462628)

  • 41. Hypoxanthine, xanthine, and uric acid concentrations in plasma, cerebrospinal fluid, vitreous humor, and urine in piglets subjected to intermittent versus continuous hypoxemia.
    Stoltenberg L; Rootwelt T; Oyasaeter S; Rognum TO; Saugstad OD
    Pediatr Res; 1993 Dec; 34(6):767-71. PubMed ID: 8108190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uric acid increases erythrocyte aggregation: Implications for cardiovascular disease.
    Sloop GD; Bialczak JK; Weidman JJ; St Cyr JA
    Clin Hemorheol Microcirc; 2016 Oct; 63(4):349-359. PubMed ID: 26598998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of inorganic phosphate on hypoxanthine transport in isolated brain microvessels.
    Cardelli P; Fiori A; Santulli MC; Ceci F; Salerno C; Savi MR; Peresempio V; Strom R
    Biochem Int; 1992 Dec; 28(5):823-34. PubMed ID: 1363191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxypurine release in cardiac disease. An indicator of general hypoxia in patients with cardiac arrest.
    Buhl L; Vilhelmsen KN; Nielsen JR
    Acta Med Scand; 1981; 209(1-2):83-6. PubMed ID: 7211492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of purine metabolism in a xanthinuric female.
    Bradford MJ; Krakoff IH; Leeper R; Balis ME
    J Clin Invest; 1968 Jun; 47(6):1325-32. PubMed ID: 5653212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of probenecid on oxypurines in plasma.
    Yamamoto T; Takahashi S; Suda M; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):510-4. PubMed ID: 2511159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Urate production in a porcine model of myocardial ischemia-reperfusion].
    Martín-Jadraque R; Montero C; Mostaza JM; López-Sendón JL; Argomaniz L; Llorente P; Martín-Jadraque L
    Rev Esp Cardiol; 1996 Apr; 49(4):281-7. PubMed ID: 8650405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal handling of hypoxanthine and xanthine in normal subjects and in four cases of idiopathic renal hypouricemia.
    Kaneko K; Fujimori S; Itoh H; Nakayama Y; Oyama H; Kanbayashi T; Miyashita H; Akaoka I
    J Rheumatol; 1988 Feb; 15(2):325-30. PubMed ID: 3361540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Release of uric acid from perfused rat heart.
    Ronca-Testoni S; Borghini F
    Ital J Biochem; 1982; 31(2):127-38. PubMed ID: 7129855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of phototherapy on serum uric acid (author's transl)].
    Böhles H; Schnall B
    Klin Padiatr; 1981 Jul; 193(4):308-10. PubMed ID: 7265799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxanthine, xanthine and uric acid in human urine and in decomposed blood.
    Petersen BB; Jorni J; Jorgensen S
    Scand J Clin Lab Invest; 1965; 17(5):460-6. PubMed ID: 5839886
    [No Abstract]   [Full Text] [Related]  

  • 52. [The hematic rate of uric acid and of xanthine bases in the pigeon and the chicken in relation to the process of uric acid synthesis in the liver of uricotelic vertebrates].
    CLEMENTI A; RICCERI G
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1439-43. PubMed ID: 13810643
    [No Abstract]   [Full Text] [Related]  

  • 53. Renal excretion of purine bases. Effects of probenecid, benzbromarone and pyrazinamide.
    Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
    Nephron; 1988; 48(2):116-20. PubMed ID: 3344050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uremic inhibition of purine uptake by rat hepatic slices.
    White AG; Nachev P
    Am J Physiol; 1975 Feb; 228(2):436-40. PubMed ID: 1119568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial hypoxanthine-guanine phosphoribosyl transferase deficiency without elevated urinary hypoxanthine excretion.
    van Dael CM; Pierik LJ; Reijngoud DJ; Niezen-Koning KE; van Diggelen OP; van Spronsen FJ
    Mol Genet Metab; 2007 Feb; 90(2):221-3. PubMed ID: 17129743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA
    J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Metabolic disorder of purine nucleotide in patients with chronic renal failure].
    Hosoya T; Tabe A; Hayashi T; Sakai O
    Nihon Rinsho; 1992 Jan; 50 Suppl():544-8. PubMed ID: 1578736
    [No Abstract]   [Full Text] [Related]  

  • 59. A teaching format in clinical pharmacology. Comparison of two xanthines and a placebo.
    Brunk SF; Ferguson RK; Toubes DB; Leaverton PE; Nordschow CD; Wilson WR
    J Clin Pharmacol New Drugs; 1973 Apr; 13(4):121-6. PubMed ID: 4487162
    [No Abstract]   [Full Text] [Related]  

  • 60. Conversion of guanine to hypoxanthine in mammalian red blood cells.
    HERSHKO A; WIND E; RAZIN A; MAGER J
    Biochim Biophys Acta; 1963 Jun; 71():609-20. PubMed ID: 13954136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.